Search Results
Sep 09, 2026, 09:00 ET Embark Launches Behavior Insights, Giving Pet Parents a Look at the DNA Behind Their Dog's Behavior
research and a lifelong love for dogs. Starting with its best-in-class canine DNA test, Embark has built a platform for scientific discovery that helps accelerate advancements in personalized dog care. Embark offers dog DNA tests that help dog owners, breeders, and veterinarians learn about their dog's
More news about: Embark Veterinary, Inc.
Sep 09, 2026, 08:00 ET 1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia
cancers that are defective in DNA homologous recombination repair. These cancer types include predominately prostate, ovarian, breast and pancreatic cancers with known mutations in DNA repair genes such as BRCA1, BRCA2 or PALB2. In preclinical models of cancers known to have DNA repair deficiency of this
More news about: 1cBio, Inc.
Sep 09, 2026, 08:00 ET Ultima Genomics to Advance Pangenome-Aware Whole Genome Sequencing Analysis at Population Scale in Collaboration with NVIDIA, using Google's DeepVariant
FREMONT, Calif., Sept. 9, 2026 /PRNewswire/ -- Ultima Genomics, a leader in ultra-high-throughput DNA sequencing, today announced a collaboration with NVIDIA to enable pangenome-aware whole genome sequencing (WGS) analysis at unprecedented scale.
More news about: Ultima Genomics
Sep 09, 2026, 08:00 ET BEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT
Exceptional Timepieces overwrite expectations to create unprecedented horological objects. With its disruptive approach of challenging convention, Hublot's DNA is transcribed in the Unico, Meca-10 and tourbillon in-house calibers, to add another tier of meaning to the Art of Fusion.Since 2026, Hublot's
More news about: Hublot SA
Sep 09, 2026, 08:00 ET BEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT
Exceptional Timepieces overwrite expectations to create unprecedented horological objects. With its disruptive approach of challenging convention, Hublot's DNA is transcribed in the Unico, Meca-10 and tourbillon in-house calibers, to add another tier of meaning to the Art of Fusion.Since 2026, Hublot's
More news about: Hublot SA
Sep 09, 2026, 08:00 ET OLTRE LA TELA: JEFF KOONS REINVENTA IL TEMPO CON HUBLOT
gli Exceptional Timepiece superano le aspettative per creare segnatempo senza precedenti. Con il suo approccio dirompente che sfida le convenzioni, il DNA di Hublot è trascritto nei calibri di manifattura di Unico, Meca-10 e Tourbillon, per aggiungere un ulteriore livello di significato all'Art of Fusion.Dal
More news about: Hublot SA
Sep 09, 2026, 08:00 ET ALÉM DA TELA: JEFF KOONS REINTERPRETA O TEMPO COM A HUBLOT
Exceptional Timepieces superam todas as expectativas com criações relojoeiras sem precedentes. Com sua disruptiva abordagem de desafiar o convencional, o DNA da Hublot é traduzido nos movimentos Unico, Meca-10 e turbilhão que ela mesma desenvolveu internamente, adicionando mais uma camada de significado à
More news about: Hublot SA
Sep 09, 2026, 08:00 ET JENSEITS DER LEINWAND: JEFF KOONS UND HUBLOT DENKEN DIE ZEIT NEU
schaffen. Die in der eigenen Manufaktur entwickelten und produzierten Uhrwerke von Hublot – Unico, Meca-10 und Tourbillonkaliber – tragen die rebellische DNA in sich, die die Marke dazu antreibt, die Konventionen ein ums andere Mal herauszufordern. Damit fügen sie der Kunst der Fusion eine weitere Bedeutungsebene
More news about: Hublot SA
Sep 09, 2026, 08:00 ET VƯỢT RA KHỎI KHUNG TRANH CANVAS: JEFF KOONS TÁI ĐỊNH NGHĨA THỜI GIAN CÙNG HUBLOT
chế; trong khi Exceptional Timepieces phá vỡ mọi kỳ vọng để tạo nên những sáng tạo chế tác đồng hồ chưa từng có. Với tinh thần thách thức quy chuẩn, DNA của Hublot được thể hiện rõ nét qua các bộ máy in-house Unico, Meca-10 và tourbillon, qua đó mở rộng thêm một tầng ý nghĩa mới cho triết lý Art of Fusion.Kể
More news about: Hublot SA
Sep 09, 2026, 07:25 ET Eddid Securities USA Partners with tZERO for Digital Asset Securities Trading and Custody
is an all-encompassing financial group centered around fintech and dedicated to integrating the latest technologies into its enterprise DNA. Eddid Securities USA Inc. is a broker-dealer registered with the SEC and a member of FINRA and SIPC, with office at 40 Wall Street in New York City.
More news about: Eddid Financial; Eddid Securities USA Inc.
Sep 09, 2026, 07:00 ET JULIEN'S AUCTIONS APPOINTS KEN CITRON CHIEF EXECUTIVE OFFICER TO LEAD NEXT ERA OF GLOBAL GROWTH
has been at the center of some of the most recognizable people and moments in entertainment history, and pop culture is truly part of the company's DNA. I'm excited to work alongside this talented team as we build on that legacy, continue to evolve the brand and find new ways to ensure Julien's remains
More news about: Julien's Auctions
Sep 08, 2026, 19:27 ET Stowers Institute partners with Google DeepMind and leading research institutions to help reveal the regulatory language of the human genome
reveal the regulatory "words" of the genomeEvery cell in the human body contains essentially the same DNA, yet different cells use that information in very different ways. Short DNA sequences called motifs act as regulatory instructions, helping control which genes are active, when they are activated
More news about: Stowers Institute for Medical Research
Sep 08, 2026, 18:35 ET The Inner Circle acknowledges Eric J. Siskind, MD as a Pinnacle Lifetime Member
Medical Center, and SUNY Upstate Hospital. He also contributed to transplant innovation through research development work involving transplant cell free DNA technologies.In addition to his clinical achievements, Dr. Siskind has authored more than 25 scientific manuscripts and book chapters and serves
More news about: The Inner Circle
Sep 08, 2026, 12:52 ET Cell Stem Cell: Die tBE-vermittelte Base-Editing-Therapie erzielt bei unterschiedlichen genetischen Hintergründen eine dauerhafte klinische Remission bei Sichelzellkrankheit und β-Thalassämie
Cas9- und Cas12a-Behandlungsschemata (<50 %) deutlich.Im Gegensatz zu Nukleasen, die auf DNA-Doppelstrangbrüche (DSBs) angewiesen sind, ermöglicht tBE eine präzise Basenumwandlung, ohne die DNA zu spalten, wodurch die Aktivierung von p53, Apoptose, große Deletionen und chromosomale Umlagerungen
More news about: CorrectSequence Therapeutics
Sep 08, 2026, 11:49 ET Groundbreaking ARUP Research Clarifies Clinical Value of Atypical Cell-Free DNA Screening Results
/PRNewswire/ -- An extensive, first-of-its-kind research study by ARUP Laboratories clarifies the clinical value of atypical findings from prenatal cell-free DNA (cfDNA) screening and their impact on pregnancy outcomes. The study, which investigated the connection between atypical prenatal cfDNA screening results
More news about: ARUP Laboratories
Sep 08, 2026, 10:15 ET Orange Insurance Exchange Goes Live on Solstice's Equinox™, Launching Three Homeowners Products Simultaneously on AI-Native Architecture
cadence, quality, and function of software delivery. "There's a real difference between AI bolted onto a legacy system and AI that's woven into the DNA of the architecture from day one, that's the line we hold ourselves to," said Travis Pine, Chief Executive Officer of Solstice Innovations. "Orange came
More news about: Solstice Innovations, Inc.
Sep 08, 2026, 09:16 ET IntelliGenome Appoints SIMED as Exclusive Distributor for CRISPR-TB™ in Peru and Ecuador
registration process in Ecuador.CRISPR-TB is an innovative molecular blood test that detects circulating Mycobacterium tuberculosis cell-free DNA, representing a novel non-sputum approach to tuberculosis detection.SIMED was selected for its strong expertise in tuberculosis diagnostics, molecular
More news about: IntelliGenome
Sep 08, 2026, 09:01 ET THE DR. MARTENS LOAFER COLLECTION: FROM SEASONAL STAPLE TO YEAR-ROUND ESSENTIAL
2026 /PRNewswire/ -- No fall wardrobe is complete without a pair of loafers, and no one does them better than Dr. Martens. Rooted in unmistakable DM's DNA, each style reimagines the classic loafer silhouette with a contemporary take, creating must have, versatile shoes, taking wearers through autumn and
More news about: Dr. Martens
Sep 08, 2026, 09:00 ET Rose BioSolutions Appoints David Enloe as Chief Executive Officer
is purpose-built to deliver end-to-end solutions for clients on industry-leading timelines and offers manufacturing across the full suite of plasmid DNA, viral vector, and cell therapies, as well as cell supply operations. Rose Bio operates facilities in Rockville, Maryland; Memphis, Tennessee; Northridge,
More news about: Rose BioSolutions
Sep 08, 2026, 09:00 ET The V Foundation for Cancer Research Awards $1.8 Million in Grants to Children's Hospital of Philadelphia Researchers
significantly increased risk of developing cancer. In Dr. MacFarland's study, researchers will pilot the use of a blood-based assay to detect tumor DNA in the bloodstream to detect cancer earlier than current screening methods. This study will also assess how liquid biopsy testing affects patients and
More news about: Children's Hospital of Philadelphia
Sep 08, 2026, 07:05 ET Cyngn Announces Organizational Realignment to Accelerate Enterprise Growth and AI-Driven Efficiency
structure lets us move faster with fewer handoffs, while improving our cost structure and extending our runway. We view this AI fluency a part of our DNA, not as a one-time efficiency gain but as a durable capability that will keep compounding as our teams get more comfortable with these tools.Data
More news about: Cyngn
Sep 08, 2026, 04:00 ET ARTEMIS II CREW LANDS AT STARMUS VIII - 15 YEARS AFTER ARMSTRONG, ALDRIN AND LEONOV LAUNCHED ITS LEGACY
Moon," said STARMUS co-founder Dr. Garik Israelian. "Neil Armstrong, Buzz Aldrin and Alexei Leonov gave STARMUS something that has remained part of its DNA ever since - the conviction that exploration has the power to change how we see ourselves and our planet."STARMUS is committed to ensuring
More news about: Starmus Foundation
Sep 08, 2026, 04:00 ET ARTEMIS II CREW LANDS AT STARMUS VIII - 15 YEARS AFTER ARMSTRONG, ALDRIN AND LEONOV LAUNCHED ITS LEGACY
Moon," said STARMUS co-founder Dr. Garik Israelian. "Neil Armstrong, Buzz Aldrin and Alexei Leonov gave STARMUS something that has remained part of its DNA ever since - the conviction that exploration has the power to change how we see ourselves and our planet."STARMUS is committed to ensuring
More news about: Starmus Foundation
Sep 08, 2026, 03:00 ET Ribbon Bio Appoints Jay Therrien as Chief Business Officer
continue to scale the business and advance our vision for the future of DNA synthesis."About Ribbon BioRibbon Bio is a cell-free DNA assembly company, transforming access to high-fidelity DNA molecules. By producing DNA independent of bacterial-mediated processes, Ribbon sidesteps many
More news about: Ribbon Bio
Sep 07, 2026, 20:00 ET Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds
hemoglobin, markedly outperforming Cas9 and Cas12a regimens (<50%).Unlike nucleases that rely on DNA double-strand breaks (DSBs), tBE enables precise base conversion without cutting DNA, avoiding p53 activation, apoptosis, large deletions, and chromosomal rearrangements. Its dual gRNA and "lock-and-key"
More news about: CorrectSequence Therapeutics